[1]
“Post-Pembrolizumab Optic Neuritis in a 57-Year Old Female with non-small cell lung carcinoma”, jor, vol. 5, no. 2, pp. 74–80, May 2022, Accessed: Sep. 22, 2026. Available: https://fortunejournals.org/ojs/index.php/jor/article/view/17435